Cargando…

Glutamate signaling through the NMDA receptor reduces the expression of scleraxis in plantaris tendon derived cells

BACKGROUND: A body of evidence demonstrating changes to the glutaminergic system in tendinopathy has recently emerged. This hypothesis was further tested by studying the effects of glutamate on the tenocyte phenotype, and the impact of loading and exposure to glucocorticoids on the glutamate signali...

Descripción completa

Detalles Bibliográficos
Autores principales: Spang, Christoph, Backman, Ludvig J., Le Roux, Sandrine, Chen, Jialin, Danielson, Patrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445477/
https://www.ncbi.nlm.nih.gov/pubmed/28545490
http://dx.doi.org/10.1186/s12891-017-1575-4
_version_ 1783238900295139328
author Spang, Christoph
Backman, Ludvig J.
Le Roux, Sandrine
Chen, Jialin
Danielson, Patrik
author_facet Spang, Christoph
Backman, Ludvig J.
Le Roux, Sandrine
Chen, Jialin
Danielson, Patrik
author_sort Spang, Christoph
collection PubMed
description BACKGROUND: A body of evidence demonstrating changes to the glutaminergic system in tendinopathy has recently emerged. This hypothesis was further tested by studying the effects of glutamate on the tenocyte phenotype, and the impact of loading and exposure to glucocorticoids on the glutamate signaling machinery. METHODS: Plantaris tendon tissue and cultured plantaris tendon derived cells were immunohisto-/cytochemically stained for glutamate, N-Methyl-D-Aspartate receptor 1 (NMDAR1) and vesicular glutamate transporter 2 (VGluT2). Primary cells were exposed to glutamate or receptor agonist NMDA. Cell death/viability was measured via LDH/MTS assays, and Western blot for cleaved caspase 3 (c-caspase 3) and cleaved poly (ADP-ribose) polymerase (c-PARP). Scleraxis mRNA (Scx)/protein(SCX) were analyzed by qPCR and Western blot, respectively. A FlexCell system was used to apply cyclic strain. The effect of glucocorticoids was studies by adding dexamethasone (Dex). The mRNA of the glutamate synthesizing enzymes Got1 and Gls, and NMDAR1 protein were measured. Levels of free glutamate were determined by a colorimetric assay. RESULTS: Immunoreactions for glutamate, VGluT2, and NMDAR1 were found in tenocytes and peritendinous cells in tissue sections and in cultured cells. Cell death was induced by high concentrations of glutamate but not by NMDA. Scleraxis mRNA/protein was down-regulated in response to NMDA/glutamate stimulation. Cyclic strain increased, and Dex decreased, Gls and Got1 mRNA expression. Free glutamate levels were lower after Dex exposure. CONCLUSIONS: In conclusion, NMDA receptor stimulation leads to a reduction of scleraxis expression that may be involved in a change of phenotype in tendon cells. Glutamate synthesis is increased in tendon cells in response to strain and decreased by glucocorticoid stimulation. This implies that locally produced glutamate could be involved in the tissue changes observed in tendinopathy.
format Online
Article
Text
id pubmed-5445477
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54454772017-05-30 Glutamate signaling through the NMDA receptor reduces the expression of scleraxis in plantaris tendon derived cells Spang, Christoph Backman, Ludvig J. Le Roux, Sandrine Chen, Jialin Danielson, Patrik BMC Musculoskelet Disord Research Article BACKGROUND: A body of evidence demonstrating changes to the glutaminergic system in tendinopathy has recently emerged. This hypothesis was further tested by studying the effects of glutamate on the tenocyte phenotype, and the impact of loading and exposure to glucocorticoids on the glutamate signaling machinery. METHODS: Plantaris tendon tissue and cultured plantaris tendon derived cells were immunohisto-/cytochemically stained for glutamate, N-Methyl-D-Aspartate receptor 1 (NMDAR1) and vesicular glutamate transporter 2 (VGluT2). Primary cells were exposed to glutamate or receptor agonist NMDA. Cell death/viability was measured via LDH/MTS assays, and Western blot for cleaved caspase 3 (c-caspase 3) and cleaved poly (ADP-ribose) polymerase (c-PARP). Scleraxis mRNA (Scx)/protein(SCX) were analyzed by qPCR and Western blot, respectively. A FlexCell system was used to apply cyclic strain. The effect of glucocorticoids was studies by adding dexamethasone (Dex). The mRNA of the glutamate synthesizing enzymes Got1 and Gls, and NMDAR1 protein were measured. Levels of free glutamate were determined by a colorimetric assay. RESULTS: Immunoreactions for glutamate, VGluT2, and NMDAR1 were found in tenocytes and peritendinous cells in tissue sections and in cultured cells. Cell death was induced by high concentrations of glutamate but not by NMDA. Scleraxis mRNA/protein was down-regulated in response to NMDA/glutamate stimulation. Cyclic strain increased, and Dex decreased, Gls and Got1 mRNA expression. Free glutamate levels were lower after Dex exposure. CONCLUSIONS: In conclusion, NMDA receptor stimulation leads to a reduction of scleraxis expression that may be involved in a change of phenotype in tendon cells. Glutamate synthesis is increased in tendon cells in response to strain and decreased by glucocorticoid stimulation. This implies that locally produced glutamate could be involved in the tissue changes observed in tendinopathy. BioMed Central 2017-05-25 /pmc/articles/PMC5445477/ /pubmed/28545490 http://dx.doi.org/10.1186/s12891-017-1575-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Spang, Christoph
Backman, Ludvig J.
Le Roux, Sandrine
Chen, Jialin
Danielson, Patrik
Glutamate signaling through the NMDA receptor reduces the expression of scleraxis in plantaris tendon derived cells
title Glutamate signaling through the NMDA receptor reduces the expression of scleraxis in plantaris tendon derived cells
title_full Glutamate signaling through the NMDA receptor reduces the expression of scleraxis in plantaris tendon derived cells
title_fullStr Glutamate signaling through the NMDA receptor reduces the expression of scleraxis in plantaris tendon derived cells
title_full_unstemmed Glutamate signaling through the NMDA receptor reduces the expression of scleraxis in plantaris tendon derived cells
title_short Glutamate signaling through the NMDA receptor reduces the expression of scleraxis in plantaris tendon derived cells
title_sort glutamate signaling through the nmda receptor reduces the expression of scleraxis in plantaris tendon derived cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445477/
https://www.ncbi.nlm.nih.gov/pubmed/28545490
http://dx.doi.org/10.1186/s12891-017-1575-4
work_keys_str_mv AT spangchristoph glutamatesignalingthroughthenmdareceptorreducestheexpressionofscleraxisinplantaristendonderivedcells
AT backmanludvigj glutamatesignalingthroughthenmdareceptorreducestheexpressionofscleraxisinplantaristendonderivedcells
AT lerouxsandrine glutamatesignalingthroughthenmdareceptorreducestheexpressionofscleraxisinplantaristendonderivedcells
AT chenjialin glutamatesignalingthroughthenmdareceptorreducestheexpressionofscleraxisinplantaristendonderivedcells
AT danielsonpatrik glutamatesignalingthroughthenmdareceptorreducestheexpressionofscleraxisinplantaristendonderivedcells